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Overview
Recent scientific advances have shown that antiretroviral therapy 
(ART) not only preserves the health of people living with HIV, but also 
dramatically lowers their risk of transmitting HIV to others by reducing 
the amount of virus in the body. These developments have transformed 
the nation’s approach to HIV prevention. By ensuring that everyone with 
HIV is aware of their infection and receiving the treatment they need, we 
can sharply reduce new infections in the United States.
This vision is central to the National HIV/AIDS Strategy, the nation’s 
roadmap for addressing HIV in the United States (see sidebar). It is also a 
core focus of CDC’s high-impact HIV prevention strategy, which aims to 
achieve the greatest possible reductions in HIV infections by making sure 
that resources go to the regions, populations and prevention strategies 
where they will have the greatest impact. And it is backed by the HIV Care 
Continuum Initiative, an effort launched by President Obama in 2013 to 
increase the impact of HIV diagnosis and care efforts.
To help gauge progress towards national goals (see sidebar) and direct 
HIV prevention resources most effectively, CDC tracks the HIV care 
continuum. The continuum is the series of steps from the time a person 
is diagnosed with HIV through the successful treatment of their infection 
with HIV medications. This fact sheet explains the various approaches and 
data used to develop the HIV care continuum, how it is used to improve 
outcomes for people living with HIV in the United States and how it helps 
guide the nation’s response to HIV.
What is the HIV Care Continuum?
The ultimate goal of HIV treatment is to achieve viral suppression, meaning the amount of HIV in the body is very low or 
undetectable. This is important for people with HIV to stay healthy, live longer and reduce their chances of passing HIV to others. 
The HIV care continuum consists of several steps required to achieve viral suppression.  Specifically, CDC tracks the 
proportion of people with HIV who are:
   Diagnosed with HIV infection
   Linked to care*, meaning they visited a heath care provider within three months after learning they were HIV positive 
   Engaged or retained in care**, meaning they received medical care for HIV infection
   Prescribed antiretroviral therapy to control their HIV infection
   Virally suppressed, meaning that their HIV viral load – the amount of HIV in the blood – is at a very low level
*  Linkage to care is calculated differently from other steps in the continuum, and cannot be directly compared to other steps. See Table 
1 on page 4 for more details. ** Based on the different ways to monitor the continuum, people with HIV in care are measured either as 
those “engaged in care” or “retained in care.” See Table 1 on page 4 for more details. 
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Objectives on HIV Diagnosis  
and Care
The National HIV/AIDS Strategy, released 
in 2010, includes several specific goals 
related to early HIV diagnosis and 
effective care, including:
   Increasing the number of HIV-positive 
individuals aware of their status to 
90 percent
   Increasing, to 85 percent, the 
proportion of newly diagnosed 
individuals who are linked to care 
within three months
   Increasing the proportion of HIV-
diagnosed individuals whose virus 
is effectively suppressed, with an 
emphasis on African Americans, Latinos 
and gay and bisexual men of all races, 
the populations most affected by HIV 
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It’s important to note that movement along the continuum is not always in one direction. For example, a person who 
achieved viral suppression might fall back to an earlier step if they do not continue to receive adequate medical care.  
In addition, not all steps depend on the previous step. 
How CDC Monitors the Continuum  
CDC currently uses two different approaches to monitor the HIV care continuum. Both are essential to monitor the nation’s 
progress and identify key HIV prevention and care needs. 
The difference between the two approaches is that they have different denominators. That is, they measure progress among 
different groups of people living with HIV:
The prevalence-based HIV care continuum shows each step of the continuum as a percentage of the total number of people 
living with HIV (“HIV prevalence”). Prevalence includes estimates of people whose infection has been diagnosed and people who 
are infected but don’t know it (“undiagnosed”). 
This approach is used to examine the care continuum among all Americans living with HIV (see Example 1).  It can also 
monitor outcomes for broad populations, such as African Americans or men who have sex with men (MSM) overall. However, 
because of certain statistical limitations, this continuum does not allow analyses within subgroups of those populations, 
such as young black MSM. 
Example 1: Prevalence-Based HIV Care Continuum, 2011
*  Linkage to care measures the percentage of people diagnosed with HIV in a given calendar year who had one or more documented viral load or CD4+ test within three months  
of diagnosis. Because it is calculated differently from other steps in the continuum, it cannot be directly compared to other steps and is therefore shown in a different color.  
See Table 1 on page 4 for more details.
Source: CDC. Vital Signs: HIV Diagnosis, Care, and Treatment Among Persons Living with HIV — United States, 2011. MMWR. 2014;63(47):1113-1117.
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How CDC Develops the Continuum 
The data for both the prevalence- and diagnosis-based continuum of 
care approaches come primarily from two CDC HIV surveillance systems: 
   The National HIV Surveillance System (NHSS) provides a range  
of information on people who are diagnosed or have died with HIV 
from every U.S. state and territory and the District of Columbia, 
including race/ethnicity, route of transmission and age. The data are 
reported to CDC by state and local health departments. This is the 
source of data for both the prevalence and diagnosis denominators. 
Data from the states and D.C. that have complete laboratory reporting 
can also be used to calculate some measures of the continuum.  
   The Medical Monitoring Project (MMP) provides a range of 
information on the experiences of people receiving HIV care and  
the outcomes of their treatment, including the number of people 
receiving care, the number prescribed ART and the number who 
achieve viral suppression. The data are reported to CDC by a sample  
of states, cities and Puerto Rico. MMP data are weighted to be 
nationally representative.
Different steps, or “bars,” within a single continuum come from different 
sources of data. For additional details on how these data sources are  
used in the two continuum approaches, see Table 1 below.  
*  Linkage to care measures the percentage of people diagnosed with HIV in a given calendar year who had one or more documented viral load or CD4+ test within three months  
of diagnosis. Because it is calculated differently from other steps in the continuum, it cannot be directly compared to other steps and is therefore shown in a different color.  
See Table 1 on page 4 for more details.
Different Approaches for 
Different Needs
While CDC’s current approaches draw 
on the best data available, there is no 
single best way to develop an HIV care 
continuum. 
Based on its intended purpose, 
each continuum may use a different 
denominator; different steps within 
one continuum may be based on 
different data sources; and some steps 
may be calculated differently in one 
continuum than another.
To select the right data sources 
and decide how to present them, 
it is important to know how the 
continuum will be used. 
 Ways of presenting the continuum will 
also continue to evolve over time, 
as better and more complete data 
become available.
Source: CDC. Men Living with Diagnosed HIV Who Have Sex with Men: Progress Along the Continuum of HIV Care – United States, 2010. MMWR. 2014;63(8):829-833.
Example 2: Diagnosis-Based HIV Care Continuum, Black MSM, 2010
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The diagnosis-based HIV care continuum shows each step of the continuum as a percentage of the number of people living with 
HIV who have been diagn  (“living with diagnosed HIV”).  
This approach gives us more detailed information about persons who are diagnosed with HIV. It can also provide a way to 
look at the continuum within more specific subgroups of affected populations, for example young black MSM  
(see Example 2) or heterosexual Latina women. 
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Linked to Care
Prescribed ART  
Viral Suppression
CDC estimates the total number of 
people living with HIV – whether 
diagnosed or not – through statistical 
modeling using NHSS data from all 
U.S. states and D.C.  
(Denominator for prevalence-based 
continuum.)
The number of people who have 
been diagnosed and are living with 
HIV infection is calculated as part of 
the HIV prevalence estimate above. 
MMP data are used to estimate those “engaged in care,” measured as the 
percentage of people living with HIV who had at least one HIV medical care visit 
during the survey’s sampling period in the observed year.
 NHSS data from the states and D.C. that have complete laboratory reporting 
are used to estimate those “in care,” measured as the percentage of diagnosed 
individuals who had at least one documented viral load or CD4+ test within 
the observation year, and “retained in care,” measured as the percentage of 
diagnosed individuals who had two or more documented viral load or CD4+ 
tests, performed at least three months apart in the observed year.   
Measures the percentage of people diagnosed with HIV in a given calendar year 
that had one or more documented viral load or CD4+ test within three months  
of diagnosis. Calculated using NHSS data from states and D.C. that have 
complete laboratory reporting.  
Because linkage to care is based on a different denominator than other 
indicators in the continuum – i.e., people diagnosed in a single year – it cannot 
be directly compared to other steps in the continuum. Therefore, linkage to 
care is often shown in a different color or separately from the other steps in the 
continuum (refer to Examples 1 and 2 in this fact sheet).
MMP data are used to estimate the number and percentage of people receiving 
medical care and who have a documented ART prescription in their medical 
records in the observed year.
MMP or NHSS data from the states and D.C. that have complete laboratory 
reporting can be used to estimate the percentage of individuals whose most 
recent HIV viral load within the observed year was less than 200 copies/mL. 
NHSS data are used to estimate 
the number of people currently 
diagnosed and living with HIV.
(Denominator for diagnosis-based 
continuum.)
Continuum Step
Prevalence-Based Continuum Diagnosis-Based Continuum
Data Sources & Definitions
Table 1: Calculating the Continuum:  CDC’s Current Data Sources, Step by Step
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How the Continuum Is Used to Monitor Progress and  
Identify Needs 
By tracking the proportion of people living with HIV who are engaged in each of the five separate steps of the HIV care 
continuum, federal and state health agencies can identify gaps and, over time, pinpoint how, where and when to intervene 
to improve outcomes along the continuum. This will ultimately help us break the cycle of HIV transmission and reduce new 
infections, while improving the health of those living with HIV.
At the national level, the HIV care continuum is used to inform decisions about how best to prioritize and target available 
resources and to monitor national progress in the response to HIV.
At the state and local levels, jurisdictions can use the HIV care continuum – compiled using local data – to determine where 
improvements are most needed and target resources accordingly.
CDC is undertaking many initiatives to improve outcomes at every stage of the HIV care continuum, including:
   Directly funding health departments and community-based organizations (CBOs) – to increase HIV testing, improve linkage 
to care, and help people receive and stay on treatment in communities bearing the greatest HIV burden.
   Providing technical assistance – to help CBOs develop the tools and skills to successfully implement effective HIV 
prevention activities for people living with HIV in their communities and to help each state develop a HIV care continuum 
that addresses its needs.
   Supporting the use of surveillance data – to identify people out of care and link them to and engage them in care.
   Researching new approaches – including studies of clinical, behavioral and structural interventions to help people with  
HIV stay in care and adhere to their medications.
   Developing guidelines – to support health care providers in delivering HIV testing, care, treatment and prevention services.
   Launching educational campaigns – to help health care providers integrate simple prevention approaches into routine  
care for people living with HIV.
